Role of Circular RNAs in Cardiovascular Disease
Authors:
- 1 August 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 76 (2) , 128-137
Abstract
Circular RNAs (circRNAs) have recently been identified as a new class of long noncoding RNAs with gene regulatory roles. These covalently closed transcripts are generated when the pre-mRNA splicing machinery back splices to join a downstream 5′ splice site to an upstream 3′ splice site. CircRNAs are naturally resistant to degradation by exonucleases and have long half-lives compared with their linear counterpart that potentially could serve as biomarkers for disease. Recent evidence highlights that circRNAs may play an essential role in cardiovascular injury and repair. However, our knowledge of circRNA is still in its infancy with limited direct evidence to suggest that circRNA may play critical roles in the mechanism and treatment of cardiac dysfunction. In this review, we focus on our current understanding of circRNA in the cardiovascular system.Keywords
This publication has 109 references indexed in Scilit:
- Cell-Type Specific Features of Circular RNA ExpressionPLOS Genetics, 2013
- Circular Intronic Long Noncoding RNAsMolecular Cell, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell TypesPLOS ONE, 2012
- Transcriptome-wide discovery of circular RNAs in ArchaeaNucleic Acids Research, 2011
- MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria via Arl2 in Neonatal Rat Cardiac MyocytesJournal of Biological Chemistry, 2010
- The DExH/D protein family databaseNucleic Acids Research, 2000
- Initiation of Protein Synthesis by the Eukaryotic Translational Apparatus on Circular RNAsScience, 1995
- Circular transcripts of the testis-determining gene Sry in adult mouse testisCell, 1993
- Scrambled exonsCell, 1991